Dr, Sherri Tenpenny

Course description:
In 2006, a new vaccine was released for teens to eliminate human papilloma viral infections, with a promise preventing cervical cancer in girls. In 2014, the use of the vaccine was expanded for use in boys, to prevent cervical condyloma (venereal warts). This was a lofty promise. In fact, Gardasil appears to be primarily risk with very little – if any – benefit at all. [2 Videos, Length: Vid 1: 36 Min, Vid 2: 41 Min, Downloadable Material, Access to Forums]

What you will learn from this course:

The number of human papilloma viruses (HPV) in circulation and the number that have been associated with cancer

The low incidence of HPV infections seen in American women leading to the release of Gardasil targeting this population of women

The truth about the incidence of cervical cancer in the US

The real meaning of CIN, cervical intraepithelial neoplasia

The critically important difference between neoplasia and neoplasm

The length of time it takes for each CIN classification to progress to the next level, including the extensive time required for CIN 3 lesions to progress to cervical cancer

The environmental risk factors necessary for the development of cervical cancer

Why the exposure of the cervical basement membrane is essential before the HPV viruses can bind to the tissue

The ingredients found in HPV vaccines and the impact of these ingredients on fertility in both boys and women

The reason why HPV has not been proven to cause cancer, and why Gardasil will remain primarily all risk with no benefit